No title
Objectives: To analyse and present the outcome of longitudinal change and possible subgroups with respect to Activities of daily living (ADL) function measured by different scales (PSMS, FAST and IADL) in patients treated with donepezil for three years (n=435). Methods: The Swedish Alzheimer Treatment Study (SATS) is an open, 3-year, multicentre study in a routine clinical setting. The patients we
